74%
of retail investor accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
74%
of retail investor accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Novozymes A-S (Class B)
Closed
0
Overview
Share price change
24h
Min
Max
Income | -15M 123M |
|---|---|
Sales | -7B 996M |
P/E Sector Avg | 41.005 35.4 |
EPS | 3.36 |
Dividend yield | 0.23 |
Profit margin | 12.333 |
Employees | 10,933 |
EBITDA | -2.2B 273M |
Recommendations | Neutral |
|---|---|
12 Months Forecast | +22.59% upside |
Dividend yield Sector Avg | 0.23% 2.74% |
|---|---|
Next Earnings | 5 May 2026 |
Market Cap | -1.6B 179B |
|---|---|
Previous open | 0 |
Previous close | 0 |
Novozymes A-S (Class B) Chart
Past performance is not a reliable indicator of future results.
Related News
Novozymes A-S (Class B) Forecast
Price Target
By TipRanks
22.59% upside
12 Months Forecast
Average 400 DKK 22.59%
High 520 DKK
Low 300 DKK
Based on 3 Wall Street analysts offering 12 month price targets forNovozymes A-S (Class B) - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Novozymes A-S (Class B)
Novonesis A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, microbial and medical cleaning services. Further, it provides corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions. Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions, comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, education, wastewater, and sewage sludge, and renewable diesel solutions; agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, diagnostics, enzyme, and biogas solutions. Furthermore, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novonesis A/S was founded in 1925 and is based in Bagsvaerd, Denmark.
Live chat